Relevant Standards for Temperature Monitoring:

Malignant Hyperthermia Association of the United States:
“MHAUS recommends core temperature monitoring for all patients given general anesthesia lasting more than 30 minutes.”

The WHO Guidelines for Safe Surgery:
Safe Surgery PDF
“Body temperature should be measured continuously in patients in whom a change is anticipated, intended or suspected. This can be done by continuous electronic temperature measurement, if available.”

American Society of Anesthesiologists- Standards for Basic Anesthesia Monitoring:
“Every patient receiving anesthesia shall have temperature monitored when clinically significant changes in body temperature are intended, anticipated or suspected.”

Association of Surgical Technologists:
AST Guideline Statement
“Measures to monitor and maintain body temperature should begin in the preoperative phase and continue into the postoperative phase of the surgical procedure. The monitoring of patient temperature is the responsibility of all surgical team members and not just the anesthesia provider.”

Relevant Standards for Catheter Securement:

2016, Infusion Therapy Standards of Practice 

“Stabilize and secure vascular access devices (VADs) to prevent VAD complications and unintentional loss of access”

“Methods used to stabilize the VAD will not interfere with assessment and monitoring of the access site and will not impede vascular circulation or delivery of the prescribed therapy.”

“Consider use of an engineered stabilization device (ESD) to stabilize and secure VADs as inadequate stabilization and securement can cause unintentional dislodgement and complications requiring VAD removal … Avoid the use of tape or sutures, as they are not effective alternatives to an ESD.”

CDC Guidelines for the Prevention of Intravascular Catheter-Related  Infections, 2011

“Catheter Securement Devices Recommendation: Use a sutureless securement device to reduce the risk of infection for intravascular catheters” (105. Category II)

Background: Catheter stabilization is recognized as an intervention to decrease the risk for phlebitis, catheter migration and dislodgement, and may be advantageous in preventing CRBSIs. Pathogenesis of CRBSI occurs via migration of skin flora through the percutaneous entry site. Sutureless securement devices avoid disruption around the catheter entry site and may decrease the degree of bacterial colonization. [105]. Using a sutureless securement device also mitigates the risk of sharps injury to the healthcare provider from inadvertent needlestick injury.”